BPC-157 and the Regulatory Landscape

This chapter explores BPC-157, a peptide noted for its healing properties, while highlighting the need for regulation to prevent black market issues akin to the opioid crisis. It addresses the challenges and inconsistencies in pharmaceutical manufacturing, as well as the safety of medical devices, emphasizing the alarming lack of human trials for many surgical products. The discussion also sheds light on the perception of alternative treatments and the complexities surrounding stem cell and peptide usage in healthcare.